Donor-specific Antibodies, Immunoglobulin-free Light Chains, and BAFF Levels in Relation to Risk of Late-onset PTLD in Liver Recipients.

Transplant Direct · 2018 · PMC6089512 · PMID 30123826

Europe PMC DOI

hedged sentences

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

of borderline significanceP = 0.09so close (0.05 < p ≤ 0.1)

Donor-specific antibodies were present in 18% of cases and 30% of controls, which yielded an inverse association of borderline significance (aOR, 0.51; 95% CI, 0.24-1.10; P = 0.09; Figure 1 ).

also in 2,624 other papers

borderline significantP = 0.09so close (0.05 < p ≤ 0.1)

Results Circulating DSAs were less common in PTLD cases than controls (18% vs 30%), although this difference was borderline significant (aOR, 0.51; 95% confidence interval [CI], 0.24-1.10; P = 0.09).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.